Newborn Screening Market - Industry Structure And Landscape Development by 2028
The global new born screening market is expected to grow with a CAGR of 10.5% during the forecast period due to key players operating in the market are adopting strategies such as collaborations and acquisitions in order to expand their product portfolio. For instance, in November 2020, Natus Medical Inc., a medical device company acquired Babybe GmbH, a company that develops its patented remote mother to baby communication technology and soft robotics for neonatal healthcare. The company’s technology will add to Natus Medical Inc.’s Newborn Care portfolio of products. Get More Insights (at) https://www.coherentmarketinsights.com/market-insight/newborn-screening-market-2192
The global new born screening market is expected to grow with a CAGR of 10.5% during the forecast period due to key players operating in the market are adopting strategies such as collaborations and acquisitions in order to expand their product portfolio. For instance, in November 2020, Natus Medical Inc., a medical device company acquired Babybe GmbH, a company that develops its patented remote mother to baby communication technology and soft robotics for neonatal healthcare. The company’s technology will add to Natus Medical Inc.’s Newborn Care portfolio of products.
Get More Insights (at) https://www.coherentmarketinsights.com/market-insight/newborn-screening-market-2192
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
NEWBORN<br />
SCREENING<br />
MARKET<br />
<strong>Market</strong> Size (2018)<br />
US$ 561.5 MN<br />
CAGR (2018 –<br />
2026)<br />
12.4%<br />
© Coherent <strong>Market</strong> Insights. All Rights Reserved
Segmentation (Scope)<br />
By Product Type By Test By Applications<br />
<br />
Assay Kits<br />
<br />
Blood Test<br />
<br />
Blood Spot Disease<br />
<br />
Hearing <strong>Screening</strong> Services<br />
<br />
Cardio Test<br />
<br />
Critical Congenital Cardiac Disease<br />
<br />
Mass Spectrometer<br />
<br />
Hearing Test<br />
<br />
Maple Syrup Urine Disease<br />
<br />
Pulse Oximetry<br />
<br />
Urine Test<br />
<br />
Hearing Disability<br />
<br />
Sickle Cell Disease<br />
<br />
Thyroid Disorder<br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
Major Drivers<br />
<br />
<br />
<br />
Increasing government<br />
support for newborn<br />
screening<br />
Advancement in screening<br />
technologies<br />
Increasing product approvals<br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
NORTH<br />
AMERICA<br />
ASIA<br />
PACIFIC<br />
Major Drivers<br />
Increasing healthcare expenditure<br />
Increasing government funding for new<br />
born screening<br />
Major Drivers<br />
Increasing incidence of premature births<br />
Rapidly increasing healthcare industry<br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
Major Players<br />
Agilent Technologies<br />
Natus Medical Inc.<br />
GE Life Sciences<br />
Bio-Rad Laboratories<br />
ZenTech S.A.<br />
Covidien PLCes<br />
AB ACIEX<br />
ParkinElmer Inc.<br />
Masimo Corporation<br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
Global New Born <strong>Screening</strong> <strong>Market</strong> Share<br />
(%), By Test Type, 2021<br />
55.6%<br />
?<br />
?<br />
?<br />
?<br />
Dry Blood Spot<br />
Test<br />
Cardiac Test Hearing Test Urine Test Others<br />
© Coherent © Coherent <strong>Market</strong> <strong>Market</strong> Insights. All All Rights Rights Reserved Reserved
Change language